Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 4

Nephrological factors may cause kidney dysfunction in patients with common variable immunodeficiency

Pages
1924–1931
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hence, in routine outpatient clinics, proteinuria should not be overlooked in this group of patients.Key words: Chronic inflammation, proteinuria, common variable immunodeficiency

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Common variable immunodeficiency (CVID) is a heterogeneous primary deficiency characterized by hypogammaglobulinemia, recurrent infections, an increased risk of autoimmune disease, malignancy, and chronic inflammation.
📊
Key Findings & Data:Materials and methods: This was a cross-sectional study involving 27 patients with CVID (15 females, 12 males; mean age, 39.88 ± 13.47 years) and 18 control subjects (10 females, 8 males; mean age, 33.83 ± 7.97 years).
💡
Conclusion & Impact:Hence, in routine outpatient clinics, proteinuria should not be overlooked in this group of patients.Key words: Chronic inflammation, proteinuria, common variable immunodeficiency
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Common variable immunodeficiency (CVID) is a heterogeneous primary deficiency characterized by hypogammaglobulinemia, recurrent infections, an increased risk of autoimmune disease, malignancy, and chronic inflammation. Proteinuria is one of the most important prognostic factors causing progression in kidney disease. Proteinuria causes tubulotoxicity, activates inflammatory markers that cause fibrosis, and consequently nephropathy progression. The data is scant in the literature regarding the inflammation and nephropathy in CVID. Hence, in the present study, we aimed to investigate the relationship between tubular dysfunction, proteinuria, and inflammation in patients with CVID. Materials and methods: This was a cross-sectional study involving 27 patients with CVID (15 females, 12 males; mean age, 39.88 ± 13.47 years) and 18 control subjects (10 females, 8 males; mean age, 33.83 ± 7.97 years). Patients were evaluated for kidney functions including glomerular filtration rate, fractional excretion of sodium, metabolic acidosis, serum/urine anion gap, 24-h urine proteinuria and, were grouped in terms of proteinuria. Blood samples obtained from the patients with CVID were taken into 2 mL EDTA tube to evaluate peripheral NK cell subgroups according to CD56 and CD16 expression and CD3, CD4, CD 8 expression to determine subtypes T cells. These cells were evaluated by flow cytometry technique. Results: Urinary density, fractional excretion of sodium, proteinuria, and metabolic acidosis are found to be higher in patients with CVID when compared to healthy controls. In the bivariate correlation analysis, proteinuria was positively correlated with age (r = 0.496, p = < 0.001), CD8+T cells percentage (r = 0.427, p = 0.02). Albumin, CRP, and CD8+T cell percentage were found to be independent variables of proteinuria. Conclusion: Increased chronic ongoing inflammation was found to be associated with proteinuria in patients with CVID. Hence, in routine outpatient clinics, proteinuria should not be overlooked in this group of patients.Key words: Chronic inflammation, proteinuria, common variable immunodeficiency

🔖

Cite This Article

AYTEKİN, G., ÇÖLKESEN, F., YILDIZ, E., ARSLAN, Ş., BALOĞLU, İ., TÜRKMEN, K. (2022). Nephrological factors may cause kidney dysfunction in patients with common variable immunodeficiency. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 4, 1924–1931. https://ajindex.com/articles/609820

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM et al. Practice parameter for the diagnosis and management of primary immunodeficiency. The Journal of Allergy and Clinical Immunology 2015
  2. 136 (5): 1186-1205. doi: 10.1016/j. jaci.2015.04.049 2. Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. Journal of Clinical Immunology 2018
  3. 38 (1): 129-143. doi: 10.1007/s10875-017-0465-8 3. Luis-Rodriguez D, Martinez-Castelao A, Gorriz JL, DeAlvaro F, Navarro-Gonzalez JF. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World Journal of Diabetes 2012
  4. 3 (1): 7-18. doi: 10.4239/wjd.v3.i1.7 4. Turkmen K. Inflammation, oxidative stress, apoptosis, and autophagy in diabetes mellitus and diabetic kidney disease: the four horsemen of the apocalypse. International Urology and Nephrology 2017
  5. 49 (5): 837-844. doi: 10.1007/ s11255-016-1488-4 5. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Annals of Internal Medicine 2003
  6. 139 (4): 244-252. doi: 10.7326/0003- 4819-139-4-200308190-00006 6. Lea J, Greene T, Hebert L, Lipkowitz M, Massry S et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Archives of Internal Medicine 2005
  7. 165 (8): 947-953. doi: 10.1001/ archinte.165.8.947 7. Shiigai T, Shichiri M. Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease. The American Journal of Kidney Diseases 2001
  8. 37 (3): 477- 483. doi: 10.1053/ajkd.2001.22069 8. Emmet M, Hoorn EJ. Serum anion gap in conditions other than metabolic acidosis. Up To Date. April 13, 2020. 9. Emmet M, Palmer BF. Urine anion and osmolal gaps in metabolic acidosis. Up To Date. March 12, 2019. 10. Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza FC et al. Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. 2012
  9. 2 (2): 139-274. 11. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. The Quarterly Journal of Medicine 1993
  10. 86 (1): 31-42. 12. Fakhouri F, Robino C, Lemaire M, Droz D, Noel LH et al. Gra